Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
1375436 | Bioorganic & Medicinal Chemistry Letters | 2005 | 5 Pages |
Abstract
The coronavirus main protease, Mpro, is considered a major target for drugs suitable to combat coronavirus infections including the severe acute respiratory syndrome (SARS). In this study, comprehensive HPLC- and FRET-substrate-based screenings of various electrophilic compounds were performed to identify potential Mpro inhibitors. The data revealed that the coronaviral main protease is inhibited by aziridine- and oxirane-2-carboxylates. Among the trans-configured aziridine-2,3-dicarboxylates the Gly-Gly-containing peptide 2c was found to be the most potent inhibitor.
Graphical abstractThe inhibition of SARS-CoV main protease by the aziridinyl peptide 2c is described.Figure optionsDownload full-size imageDownload as PowerPoint slide
Keywords
Related Topics
Physical Sciences and Engineering
Chemistry
Organic Chemistry
Authors
Erika Martina, Nikolaus Stiefl, Björn Degel, Franziska Schulz, Alexander Breuning, Markus Schiller, Radim Vicik, Knut Baumann, John Ziebuhr, Tanja Schirmeister,